Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236103 · ClinicalTrials.gov registry record · NA
AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 900
- Enrollment target
NCT03236103: Completed NA study, sponsored by Mayo Clinic.
NCT03236103 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 900 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03236103, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
Study Summary
The investigators are doing this research to investigate whether multifaceted preventive measures for newly hospitalized ventricular assist device (VAD) patients will reduce the Acute Kidney Injury (AKI) occurrence rate, progression and associated complications
Primary Outcome
The AKIN staging system has 3 stages: 1) serum creatinine increase ≥ 26.5 umol/L or increase to 1.5-2.0 fold from baseline, OR urine output \<0.5 ml/kg/h for 6 h; 2) serum creatinine increase \> 2.0-3.0 fold from baseline OR urine output \<0.5 ml/kg/h for 12 h; 3) serum creatinine increase \>3.0 fold from baseline OR serum creatinine ≥354 umol/l with an acute increase of at least 44 umol/l or need for Renal Replacement Therapy (RRT) OR urine output \<0.3 ml/kg/h for 24 h OR anuria for 12 OR need
Interventions
- OTHER Clinical Recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2017-05-19 |
| Est. Completion | 2019-04-08 |
| Phase | NA |
What the finished NCT03236103 record still lists
NCT03236103 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower).
The record links to 0 conditions, and to 1 intervention - of which Clinical Recommendations is the first listed.
NCT03236103 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03236103 about?
NCT03236103 is a clinical study titled "AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events.". The investigators are doing this research to investigate whether multifaceted preventive measures for newly hospitalized ventricular assist device (VAD) patients will reduce the Acute Kidney Injury (AKI) occurrence rate, progression and associated complications
What is the current status of trial NCT03236103?
This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2017-05-19. Estimated completion is 2019-04-08.
What interventions are being tested in trial NCT03236103?
The interventions under investigation include: Clinical Recommendations (OTHER).
Who is sponsoring clinical trial NCT03236103?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03236103's enrollment target sits among peer trials
900 124th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI